Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

PZ Cussons swings to first-half profit, shares rally

(Sharecast News) - PZ Cussons rallied on Tuesday after the Imperial Leather maker said it had returned to profit in the first half and remains on track to meet full-year expectations. In results for the six months to 30 November 2024, the company said it swung to a statutory pre-tax profit of £6.4m from a loss of £94.2m in the same period a year earlier. On an adjusted basis, pre-tax profit fell to £19.8m from £26.1m.

Revenue declined 10% to £249.3m, mainly due to the 55% devaluation of the Nigerian Naira versus sterling.

Chief executive Jonathan Myers said: "Trading has been in line with expectations during the first half of our financial year and, together, three of our priority markets - the UK, Indonesia and ANZ - have delivered solid overall like for like revenue growth of 2%.

"New product innovation, competitive brand activation and increased retail distribution have combined to deliver the strongest performance in our UK business for three years, thanks in part to particularly successful Christmas sales for Sanctuary Spa gifting.

"Indonesia recorded a third consecutive quarter of growth and in ANZ our brands have continued to grow share, albeit against a backdrop of market softness."

At 0915 GMT, the shares were up 7.4% at 85.30p.

Russ Mould, investment director at AJ Bell, said: "Imperial Leather maker PZ Cussons' latest numbers may not have a clean bill of health but there were enough positive areas to impress the market. A beaten down share price also meant investors were of a mind to give the company the benefit of the doubt.

"PZ Cussons has been beset by challenges relating to its Nigerian business and the devaluation of the country's naira currency. A stabilised situation and a strong showing in other geographies gave shareholders some hope the worst of its problems are behind it."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.